Clinical Scorecard: Prevalence of Women in the US Who Have Never Underwent Cervical Cancer Screening from 2005 to 2023

At a Glance

Key Highlights

• Percentage of women aged 21-29 who never screened rose from 12.5% in 2005 to 31.9% in 2023.
• Percentage of women aged 30-65 who never screened increased from 5.3% in 2005 to 14.8% in 2023.
• HPV vaccination among women aged 21-29 increased from 5.7% in 2008 to 54.0% in 2019.
• Disparities in never-screening exist by race, education, and insurance status.
• Cervical cancer incidence increased by over 2% annually for regional and distant stages after 2017.

Guideline-Based Recommendations

Diagnosis

• Assess cervical cancer screening history in eligible women.

Management

• Implement targeted outreach to populations with high rates of never screening.

Monitoring & Follow-up

• Track cervical cancer incidence trends by age and stage.

Risks

• Increased risk of cervical cancer among women who have never been screened.

Patient & Prescribing Data

Women aged 21 to 65 years, particularly those in the 21-29 age group.

Emphasis on HPV vaccination and regular screening to prevent cervical cancer.

Clinical Best Practices

• Encourage regular cervical cancer screening starting at age 21.
• Promote HPV vaccination among eligible populations.
• Address sociodemographic disparities in access to screening.

Related Resources & Content

• US Cancer Statistics
• National Health Interview Survey